Did you know The European Medicines Agency (EMA) has launched a dedicated web page with all the need-to-know information for H2020 funding applicants?
Created specifically with academic researchers in mind, the page offers access to all the most relevant information that may be help you to apply for H2020 funding efficiently.
Academic researchers in the field of medicine development, who may qualify for funding under the ‘Health, demographic change and wellbeing‘ thematic area of the Horizon 2020 work programme, running from 2018-2020, are advised to visit the page and check their eligibility.
With forthcoming deadlines in early 2018, researchers are looking for ways to increase the impact of their H2020 proposals, making the launch of this page timely.
You can find the page here.
How can the EMA support you?
Horizon 2020 applicants and grantees can request scientific advice at any stage of development of a medicine or a novel methodology. Incorporating scientific advice from EMA or national regulators can substantially strengthen the scientific quality and the potential impact of their research proposals.
Essential considerations for successful qualification of novel methodologies
The EMA qualification of novel methodologies (e.g. biomarkers, imaging methods and others) is a voluntary scientific pathway to establish the regulatory acceptability of a specific use of a methodology for the development of medicinal products. The EMA has highlighted the most important points to consider in a useful two-pager.
Support for Academia
You can also find information on the EMA’s most relevant activities to academia on a separate webpage.